Mainly intellectual property (IP) issues Down Under

Alphapharm v Lundbeck per se

The Full Federal Court has held that the (+) enantiomer of citalopram is itself a pharmaceutical substance per se and so eligible for term extension

Productivity Commission to review all IP laws

Minister announce Productivity Commission to review Australia’s IP laws

Innovation patent consultation on the consultation

IP Australia issues consultation paper on ACIP’s report into the innovation patent system

Australian Intellectual Property Report 2015

IP Australia has released the Australian Intellectual Property Report 2015, with statistics on IP filings and grants and trends.

Springboard injunctions and patents

Beach J accepted that springboard injunctions are available for patent infringement, but refused the grant on the facts.

ACCC loses antitrust case against Pfizer

Flick J rules that Pfizer did not breach antitrust rules by trying to maintain sales of Lipitor after it came off patent.

The statutory right to terminate a patent licence

MPEG LA licensed 3 groups of patents to Regency Media for the production of dvdd. After some, but not all, expired, Regency sought to exercise its rights under s 145 of the Patents Act 1990 to terminate ….

Securities over IP

Transition period to register security interest claims over IP expires on 31 January 2014

Summer must be over …

IP Australia has released a consultation paper, with draft exposure legislation, for an Intellectual Property Laws Amendment Bill 2014. Comments by 7 Feb 2014.

Apotex v Sanofi

The High Court has upheld the patentability of methods of medical treatment.